Ascendis Pharma AS (A71) — Financial Flexibility Index
Ascendis Pharma AS (A71) has a Financial Flexibility Index of -0.01x as of March 2026. Free cash flow of €-7.72 Million (operating CF €-7.72 Million minus capex €0.00) represents 0% of total liabilities (€1.52 Billion). Check Ascendis Pharma AS (A71) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ascendis Pharma AS Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Ascendis Pharma AS across 10 annual periods. For the full cash flow conversion analysis, see A71 operating cash flow.
Annual Financial Flexibility Index for Ascendis Pharma AS (2016–2025)
Year-by-year free cash flow to debt coverage for Ascendis Pharma AS. Explore Ascendis Pharma AS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.04x | €62.38 Million | €53.90 Million | €1.47 Billion | ▲ +118.0% |
| 2024 | -0.24x | €-304.77 Million | €-306.20 Million | €1.29 Billion | ▲ +50.5% |
| 2023 | -0.48x | €-464.92 Million | €-467.36 Million | €971.28 Million | ▲ +17.8% |
| 2022 | -0.58x | €-481.21 Million | €-495.70 Million | €826.39 Million | ▲ +70.2% |
| 2021 | -1.96x | €-393.94 Million | €-417.65 Million | €201.29 Million | ▼ -9.7% |
| 2020 | -1.78x | €-251.69 Million | €-271.55 Million | €141.08 Million | ▲ +16.8% |
| 2019 | -2.14x | €-170.78 Million | €-175.94 Million | €79.62 Million | ▲ +38.7% |
| 2018 | -3.50x | €-136.15 Million | €-138.80 Million | €38.92 Million | ▲ +11.7% |
| 2017 | -3.96x | €-94.16 Million | €-95.10 Million | €23.77 Million | ▲ +10.4% |
| 2016 | -4.42x | €-59.51 Million | €-60.18 Million | €13.46 Million | — |